Dihydrogalanthamine (hydrobromide)

• Description:

  Dihydrogalanthamine hydrobromide is an acetylcholinesterase inhibitor. Dihydrogalanthamine hydrobromide can be used in research on neurological diseases such as sequelae of poliomyelitis and myasthenia gravis[1].

• UNSPSC:

  12352005

• Hazard Statement:

  H301-H311-H331

• Target:

  Cholinesterase (ChE)

• Related Pathways:

  Neuronal Signaling

• Applications:

  Neuroscience-Neuromodulation

• Field of Research:

  Neurological Disease

• Smiles:

  OC1C=C2CCN(CC3=CC=C(C4=C3C2C(C1)O4)OC)C.Br

• Molecular Formula:

  C17H22BrNO3

• Molecular Weight:

  368.27

• Precautions:

  P260-P264-P270-P271-P280-P302+P352-P304+P340-P330-P361-P363-P405-P501

• References & Citations:

  [1]Mroczek T. Highly efficient, selective and sensitive molecular screening of acetylcholinesterase inhibitors of natural origin by solid-phase extraction-liquid chromatography/electrospray ionisation-octopole-orthogonal acceleration time-of-flight-mass spectrometry and novel thin-layer chromatography-based bioautography. J Chromatogr A. 2009 Mar 20;1216 (12) :2519-28.

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported

• CAS Number:

  [69353-21-5]